Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the ACS journal Industrial & Engineering Chemistry Research the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar, or glucose, level and can automatically release insulin as needed.
Type 1 diabetes, previously known as juvenile diabetes, affects about 1.25 million Americans. About 200,000 of them are under 20 years old. The condition arises when a person’s own immune system destroys the pancreas cells that make insulin, the hormone that converts blood sugar into energy. To make up for this loss of insulin production, patients must take insulin daily. Current delivery methods involve multiple daily injections or insulin pump therapy, both requiring the user to actively track glucose and calculate the needed insulin dose. There is also a significant time lag between when a dose is needed and when it can take effect. Francis J. Doyle III and colleagues wanted to find a way to make monitoring and insulin delivery automatic and needle-free.
The researchers designed an algorithm that monitors blood sugar levels and computes an insulin dose that it delivers quickly and automatically when necessary. The algorithm is designed to work with implanted devices, specifically with an artificial pancreas, and would overcome the delays experienced with current devices. Computer testing of the algorithm simulated the rise and fall of glucose that would correspond to meals and an overnight period of sleep. The artificial pancreas maintained blood glucose within the target range nearly 80 percent of the time. The researchers say they will soon test the device in animals.
The Latest on: Diabetes
via Google News
The Latest on: Diabetes
- Experts say chemicals found in furniture, common household items could cause diabeteson November 28, 2020 at 9:29 am
They say some common household chemicals can cause offspring to develop diabetes. Flame retardant chemicals are added to everything. From furniture, to upholstery, to electronics, it’s all over our ...
- Type 2 diabetes: Diabetics move up the priority list for COVID jab - superseding over-65son November 28, 2020 at 2:20 am
TYPE 2 DIABETICS are considered "clinically vulnerable" to a serious infection from coronavirus. As the roll-out of vaccinations nears, diabetics have moved higher up on the priority list.
- Covid-19 and Obesity: Over 65 per cent of young Indians worried about BMI, diabetes, weight loss, reveal Practo insightson November 27, 2020 at 4:57 am
The correlations between Coronavirus and obesity has been one of the most discussed concerns during the pandemic.
- Managing HIV and diabetes together: South African patients tell their storieson November 27, 2020 at 2:01 am
Care for patients with more than one disease is fragmented and uncoordinated. This is can cost patients time, effort and lost wages.
- For diabetes patients, a year-long program to change the way they eat, exerciseon November 27, 2020 at 2:00 am
Weight loss surgery, some say, dates back to the 10th century when the King of Leon in Spain was dethroned because he was too overweight to ride a horse or pick up a sword.
- Type 2 diabetes warning - four fruits that could be raising your blood sugar levelson November 26, 2020 at 8:00 pm
TYPE 2 diabetes management could be described as a boxing match against high blood sugar levels. To help you land a decisive blow against high blood sugar levels, certain dietary modifications are ...
- New Study Pinpoints How Mediterranean Diet Reduces Diabetes Riskon November 26, 2020 at 7:43 am
A 20-year follow-up of participants in the Women's Health Study unveils some of the mechanisms by which the Mediterranean diet is believed to reduce the risk of type 2 diabetes.
- Protein commonly screened for in pregnancy is linked to gestational diabeteson November 26, 2020 at 2:34 am
Laboratory research and analysis of epidemiological data by Silvia Corvera, MD, and Tiffany Moore Simas, MD, MPH, MEd, and colleagues show that low levels of a protein commonly seen in screening tests ...
- Researchers elucidate the action mechanism of incretin-based drugs in treatment of diabeteson November 25, 2020 at 9:19 pm
An international research group has clarified the action mechanism of incretin-based drugs in the treatment of diabetes.
- NHS Thumbs Up to CGM for Pregnant Type 1 Diabetes Patientson November 25, 2020 at 8:55 am
As CGM is made available for type 1 diabetes pregnancies in the UK, an audit has underscored the association between raised A1c levels and poor outcomes in all pregnant patients with diabetes.
via Bing News